RVNC 3Q19 results—pro-forma cash=$214M*: https://investors.revance.com/news-releases/news-release-details/revance-completes-enrollment-aspen-1-phase-3-pivotal-trial The BLA will be submitted during November, according to the PR. Guidance for 2019 operating cash burn remains unchanged at $148-158M. *Including $5M payment from Mylan, which has not yet been received.